Asklepios BioPharmaceutical Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Asklepios BioPharmaceutical Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011821
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Asklepios Biopharmaceutical Inc (AskBio) is a biotechnology company that develops and markets novel protein and cellular based therapies. The company has developed library of rAAV biological nano particles that provides unsurpassed transduction. Its products include such as biostrophin, AskBio009, BNP-CHF, BNP-TLE, BNP-FVIII, BNP-RP and BNP-OA. AskBio also offers products for the treatment of muscular dystrophy, hemophilia B, congestive heart failure, epilepsy, hemophilia A, retinitis pigmentos a and osteoarthritis. The company collaborates with corporate, foundation, and academic organizations. It caters to pharmaceutical and biotechnology companies throughout the country. AskBio is headquartered in Chapel Hill, North Carolina, the US.

Asklepios BioPharmaceutical Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Asklepios BioPharmaceutical Inc, Medical Devices Deals, 2011 to YTD 2017 9
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Asklepios BioPharma Forms Joint Venture with Columbus Venture 11
Licensing Agreements 12
Calimmune Enters into Licensing Agreement with Asklepios BioPharma 12
Asklepios BioPharma Enters into Licensing Agreement with AveXis 13
Benitec Biopharma Enters into Licensing Agreement with Asklepios BioPharma 14
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Duplex Gene Therapy Vector Technology 15
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Intra-Strand Base-Pairing Technology 16
Asklepios BioPharma Enters Into Licensing Agreement With REGENX Biosciences For Hemophilia A 17
Acquisition 18
Baxter International Acquires Chatham Therapeutics from Asklepios BioPharma 18
Asklepios BioPharmaceutical Inc – Key Competitors 19
Asklepios BioPharmaceutical Inc – Key Employees 20
Asklepios BioPharmaceutical Inc – Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Key Facts 2
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Asklepios BioPharmaceutical Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Asklepios BioPharmaceutical Inc, Medical Devices Deals, 2011 to YTD 2017 9
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Asklepios BioPharma Forms Joint Venture with Columbus Venture 11
Calimmune Enters into Licensing Agreement with Asklepios BioPharma 12
Asklepios BioPharma Enters into Licensing Agreement with AveXis 13
Benitec Biopharma Enters into Licensing Agreement with Asklepios BioPharma 14
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Duplex Gene Therapy Vector Technology 15
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Intra-Strand Base-Pairing Technology 16
Asklepios BioPharma Enters Into Licensing Agreement With REGENX Biosciences For Hemophilia A 17
Baxter International Acquires Chatham Therapeutics from Asklepios BioPharma 18
Asklepios BioPharmaceutical Inc, Key Competitors 19
Asklepios BioPharmaceutical Inc, Key Employees 20

★海外企業調査レポート[Asklepios BioPharmaceutical Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Foster Poultry Farms, Inc.:企業の戦略的SWOT分析
    Foster Poultry Farms, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Grundfos Holding AS:企業の戦略的SWOT分析
    Grundfos Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Checkpoint Systems, Inc.:企業の戦略・SWOT・財務分析
    Checkpoint Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Checkpoint Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Pioneer Food Group Ltd:企業の戦略・SWOT・財務情報
    Pioneer Food Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Pioneer Food Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • QVC Inc:企業の戦略的SWOT分析
    QVC Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Schroders Plc:企業の戦略・SWOT・財務情報
    Schroders Plc - Strategy, SWOT and Corporate Finance Report Summary Schroders Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Keane Group Inc (FRAC):企業の財務・戦略的SWOT分析
    Keane Group Inc (FRAC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Westinghouse Air Brake Technologies Corp:企業の戦略・SWOT・財務分析
    Westinghouse Air Brake Technologies Corp - Strategy, SWOT and Corporate Finance Report Summary Westinghouse Air Brake Technologies Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Kwang Dong Pharmaceutical Co Ltd (009290):製薬・医療:M&Aディール及び事業提携情報
    Summary Kwang Dong Pharmaceutical Co Ltd (Kwang Dong) is a drug manufacturer that develops, manufactures and supplies pharmaceuticals, health drinks and supplements. The company’s pharmaceutical products comprise OTC drugs, ETC drugs, general supplements, OTC drinks, consumer drinks, functional drin …
  • Tunstall Americas:企業の戦略的SWOT分析
    Tunstall Americas - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Daisy IT Group Ltd:企業の戦略的SWOT分析
    Daisy IT Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Epigenomics AG (ECX):医療機器:M&Aディール及び事業提携情報
    Summary Epigenomics AG (Epigenomics) is a molecular diagnostics company which develops and commercializes in-vitro diagnostic (IVD) tests for screening, early detection and diagnosis of cancer. Its lead product, Epi proColon is a blood-based test for rapid detection of colorectal cancer; and Epi pro …
  • InnoPharma Inc-製薬・医療分野:企業M&A・提携分析
    Summary InnoPharma Inc (InnoPharma), a subsidiary of Pfizer Inc is a healthcare products provider that develops generic and pharmaceutical products. The company develops formulations, which include solutions, suspensions, lyophilized, emulsions, liposomes, lipid complexes, polypeptides and carbohydr …
  • WB Electronics SA :企業の戦略・SWOT・財務情報
    WB Electronics SA - Strategy, SWOT and Corporate Finance Report Summary WB Electronics SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Orica Limited:戦略・SWOT・企業財務分析
    Orica Limited - Strategy, SWOT and Corporate Finance Report Summary Orica Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Watt’s S.A.:企業の戦略・SWOT・財務情報
    Watt's S.A. - Strategy, SWOT and Corporate Finance Report Summary Watt's S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Sunrise Coal LLC:企業の戦略・SWOT・財務情報
    Sunrise Coal LLC - Strategy, SWOT and Corporate Finance Report Summary Sunrise Coal LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Phoenix Global Resources Plc (PGR):企業の財務・戦略的SWOT分析
    Phoenix Global Resources Plc (PGR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • European Institute of Oncology:製薬・医療:M&Aディール及び事業提携情報
    Summary European Institute of Oncology (IEO) is a research institute that conducts clinical and scientific research on cancer prevention, early diagnosis and treatment of cancer. The institute offers medical care services for breast tumors, lung tumors, cervical tumors, endometrial tumors, thoracic …
  • Lifetech Scientific (Shenzhen) Co Ltd:企業の製品パイプライン分析2018
    Summary Lifetech Scientific (Shenzhen) Co Ltd (Lifetech Shenzhen), a subsidiary of Lifetech Scientific Corp, is a medical device company that offers minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases. The company provides products such as dilator, o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆